Drugs / 123-I MNI-187
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00456417 | Apr → Dec 2007 | Alzheimer disease | Institute for Neurodegenerative Disorders | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 123-I MNI-187 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00456417 ↗ |
| Modality | Diagnostic / imaging agent | “assess 123-I MNI-187 SPECT imaging as a tool to detect ß-amyloid deposition” NCT00456417 ↗ |